ARID1A and cancer: ARID1A is mutated in ovarian clear cell, endometroid, and uterine endometroid carcinomas, among other cancer types (Jones et al., 2010; Guan et al., 2011; Caumanns et al., 2018; Xu and Tang, 2021).